Makes sterile intravenous solutions and infusion systems for hospitals and healthcare providers.
Jun 2026Revenue $11.5B/yrExpenses $11.7B/yr
No trend
Figures by year
When will Baxter International be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $11.5B and expenses $11.7B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $11.2B | $11.6B | −$308M |
| Dec 2024 | $10.6B | $10.6B | $14.0M |
| Dec 2023 | $10.4B | $9.65B | $707M |
| Dec 2022 | $10.1B | $12.9B | −$2.85B |
| Dec 2021 | $12.1B | $10.8B | $1.35B |
| Dec 2020 | $11.7B | $10.1B | $1.62B |
| Dec 2019 | $11.4B | $9.59B | $1.77B |
| Dec 2018 | $11.1B | $9.52B | $1.58B |
| Dec 2017 | $10.6B | $9.30B | $1.29B |
| Dec 2016 | $10.2B | $9.42B | $745M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.